1. Introduction {#s0005}
===============

Since malaria eradication is on the global health agenda again, non-human primates as source for *Plasmodium* infections in humans have received increased attention ([@bb0005]). In this context, the simian *Plasmodium brasilianum* is particularly interesting. In 1908, a quartan malaria parasite was identified by Gonder and von Berenberg-Gossler in an imported 'bald-headed uakari' (*Cacajao calvus*) and named *P. brasilianum*, the quartan malaria parasite of New World monkeys in Latin America ([@bb0010]). *P. brasilianum* resembles the human quartan parasite *Plasmodium malariae* under the microscope, but early cross-species experimental infections by subcutaneous transfer of parasitized blood from black spider monkeys in the 1930s were unsuccessful. Hence, the names of two distinct parasites were maintained ([@bb0015]).

Later investigations in the 1960s demonstrated that humans could very well be experimentally infected with *P. brasilianum* from monkeys, and, vice versa, New World monkeys could be experimentally infected with *P. malariae* from humans ([@bb0015; @bb0020]). Moreover, studies in the 1980s showed that monoclonal antibodies against the circumsporozoite protein (CSP) of *P. malariae* cross-reacted and even neutralized the infectivity of *P. brasilianum* sporozoites to monkeys and vice versa ([@bb0025]). Sequencing of the gene coding for CSP confirmed the identity of this otherwise species-specific epitope in the two parasites ([@bb0030]).

Another common tool for the molecular species identification of malaria parasites is the gene for the small subunit (18S) of ribosomes ([@bb0035]). In 1999, Fandeur et al. analyzed the 18S gene sequences from quartan malaria parasites (*P. brasilianum*) found in four monkey species from French Guiana with the highest prevalence in *Alouatta* monkeys ([@bb0040]). The similarity between 18S sequences from *P. brasilianum* and *P. malariae* is more than 99% differing only in single nucleotide polymorphisms (SNPs). SNPs are distributed at random like in the genetic pool of one single species, and no distinctive marker has been identified so far.

Unlike other human *Plasmodium* species, no whole genome sequence is available for quartan malaria parasites. We reviewed other published gene targets (msp-1, dhfr, cytochrome b, microsatellite DNA markers) and found striking homologies in all the markers without any specific identifying SNPs between the two parasite types ([@bb0040; @bb0045; @bb0050]). The two parasites are nowadays perceived as variants of the same species, which had specialized on different hosts. Or, in practical terms, when quartan malaria parasites were identified in monkeys, they were designated as *P. brasilianum.* Conversely, when quartan malaria parasites were detected in humans, they were classified as *P. malariae.* Thus, the infected host determined the *Plasmodium* designation.

At the time of writing, altogether thirteen 18S sequences of *P. brasilianum* and thirty-four 18S sequences of *P. malariae* were registered in the NCBI GenBank nucleotide database. Sero-epidemiological studies in Brazil and French Guyana already suggested that non-human primates might constitute a natural reservoir for human malaria, and may contribute to the maintenance of foci for *P. malariae* ([@bb0055]). However, as naturally-acquired infections with parasites termed as *P. brasilianum* were never described in humans ([@bb0060]), the idea of host specificity was upheld and the classification of *P. brasilianum* as an independent *Plasmodium* species was retained.

Amazonas, the most southern federal state of Venezuela, is bordering Colombia to the west and Brazil to the east. Half of the population belongs to one of eighteen indigenous ethnic groups with the Yanomami representing one of the largest Amerindian communities. These seminomadic Indians live on both sides of the frontier between Venezuela and Brazil. On the Venezuelan side, about 12,000 Yanomami inhabit the vast forest area where the Orinoco originates and the Casiquiare river bifurcates towards the southern Amazon ([@bb0065; @bb0070]).

In a traditional Yanomami village, all persons live under one common roof, *shabono*, consisting of a circular open wooden construction that accommodates up to 400 people. Daily life takes place "open air" and the night is spent in hammocks. Many *shabonos* are difficult to reach and are several days walking distance to the nearest health post. It is estimated that around 5000 Yanomami have retreated into the deep jungle with little or no contact to Western culture ([@bb0065]). As forest-dwelling people, Yanomami hunt monkeys as a food source and incorporate them as household\'s pets.

Overall, *P. vivax* is predominant in Amazonas with roughly 85% of all detected parasites, but the distribution pattern of the malaria species is variable and contingent upon the geographic settlement of the ethnic groups. For example, a pilot study conducted in Yanomami communities from the Upper Orinoco revealed that nearly half of the malaria positive samples were *P. malariae* ([@bb0065]). In contrast, no infections caused by *P. malariae* were detected among indigenous Piaroa from the Middle Orinoco basin ([@bb0075]). Interestingly, Yanomami communities have also the highest *P. falciparum* rates (40.3%) compared to other ethnic groups in the region (8.7--22.4%) ([@bb0080]).

The current study was carried out to identify and characterize *Plasmodium* species in the Venezuelan Amazon. Specifically, we investigated quartan malaria cases in Yanomami communities living in remote areas of the Alto Orinoco Casiquiare Biosphere Reserve where humans and non-humans live in such close vicinity that they could be concurrent reservoirs of transmission.

2. Materials and methods {#s0010}
========================

2.1. Samples {#s0025}
------------

Samples for this study originate from surveys in the Yanomami communities of Ocamo, Mavaca, Koyowe, and Platanal situated in the Upper Orinoco area near the Brazilian border, which were carried out as part of governmental malaria and onchocerciasis control activities in the region between 2005 and 2007. Ethical approval was obtained by the Ethical Committees of the *Servicio Autonomo Centro Amazónico de Investigación y Control de Enfermedades Tropicales 'Simon Bolivar'* (SA-CAICET), Puerto Ayacucho, Venezuela, and the London School of Hygiene & Tropical Medicine, London (LSHTM), UK.

When the team---consisting of medical doctors, scientists and health workers---arrived in a *shabono*, people were invited for a gathering. Malaria control and research activities were explained with the help of translators. Special importance was given to the presence of elders and leaders of the community. Informed consent was obtained orally. All individuals who felt sick were examined, diagnosed and treated for malaria, or the respective disease, according to the guidelines of the Venezuelan Health Ministry ([@bb0065]). The ages of the patients were estimated as the Yanomami have no counting system.

Thick and thin blood smears were taken from individuals who presented with a history of fever and/or headache and/or malaise. Blood samples were collected by finger prick and stored on filter papers. 633 samples were used for the retrospective screening to investigate the molecular genetics of *P. malariae* parasites.

2.2. DNA extraction and PCR diagnosis {#s0030}
-------------------------------------

Parasite DNA from field samples was extracted from dried blood spots on filter paper using a commercial extraction kit (QIAamp DNA Blood Mini Kit, Qiagen). Screening for *Plasmodium* spp. infection was carried out by conventional nested-PCR assay with genus and species-specific primers based on the small subunit ribosomal RNA genes (18S) described previously by [@bb0035].

Genomic DNA of the *P. brasilianum* Peruvian III strain (MR4-349) was obtained from the Malaria Research and Reference Resource Center (MR4) to generate reference sequences for analyses at the University of New Mexico School of Medicine, Albuquerque, NM, USA.

2.3. 18S: development of new primers and sequencing {#s0035}
---------------------------------------------------

Though a *P. malariae*-specific PCR assay by [@bb0035] is sensitive and typically employed in the differential diagnosis of species, the 145 bp product of this primer set is too short for extensive sequence analysis. Therefore, we designed new sequencing primers targeting an amplicon spanning the entire variable region 5 (V5), one of the eight highly variable regions in the 18S gene which has considerable sequence variations among *Plasmodium* species. In addition we amplified three variable domains (V4, V5, V7) from the genomic DNA of *P. brasilianum* Peruvian III strain obtained from MR4.

Primer sequences were selected from unique and common regions for *P. malariae* and *P. brasilianum* species. The first primer pair (Pm18S Outer-F and Pm18S Outer-R) amplifies an 808-bp fragment. The second set of nested primers (Pm18S Inner-F and Pm18S Outer-R) amplifies a 763-bp fragment. All amplified samples were purified using Exo-SAP It Kit (USB) and sequenced bi-directionally using forward and reverse primers. Details of primer sequences, PCR amplification, and sequencing methods are shown in the appendix.

2.4. CSP: primers and sequencing {#s0040}
--------------------------------

For CSP gene amplification, primers were used from the conserved regions flanking the central repeat region that contains immunodominant epitopes. The amplified CSP gene fragment from each isolate was purified using Exo-Sap It kit (USB), cloned using a TOPO TA cloning kit (Invitrogen), and transformed into TOP10 competent *Escherichia coli* cells (Invitrogen). We sequenced at least 3 clones from each isolate using M13 primers and gene specific internal primers. Details of the methods are given in the appendix.

2.5. Sequence analysis of 18S and CSP gene {#s0045}
------------------------------------------

For the 18S gene, sequences were aligned and edited using the Vector NTI ContigExpress program version 10 (Invitrogen). Nucleotide sequences generated from each isolate were queried against the NCBI GenBank nucleotide database using BLASTN for similarity search. Out of the total 47 published sequences of *P. malariae* and *P. brasilianum*, 23 sequences overlapped with the amplified target. The remaining 24 sequences were amplified from regions different from Snounou et al. primer site. Detailed information about source, origin, and accession number of all published 18S gene sequences is listed in the supplementary (appendix). A *Plasmodium* phylogenetic tree based on the 18S gene was constructed using the Kimura 3-parameter implemented in MEGA software ver. 6.0 ([@bb0085]). *Theileria* sp. (GenBank Ac. [AF162432](ncbi-n:AF162432){#ir0235}) was used as outgroup. The reliability of the tree was assessed by the bootstrap significance test with 1000 replications. The final tree was refined using the program FigTree version 1.4.2 (<http://tree.bio.ed.ac.uk/software/figtree/>). The nucleotide diversities were calculated using DnaSP ([@bb0090]). The maximum likelihood genetic distances based on Kimura 3-parameter, modeled with gamma distribution (shape parameter = 0.21) were calculated with MEGA ver. 6.0. For distance calculation, the best suited maximum likelihood model was obtained by using Modeltest implemented in MEGA ver.6.0. The comparable 18S gene (A-type) sequences of other *Plasmodium* spp. for the analyses were obtained from NCBI GenBank and listed in the appendix. The sequence alignments that were used to infer phylogenetic relationships are available from the authors on request.

For the CSP gene, each plasmid sequence containing the CSP gene fragment was aligned using the Vector NTI ContigExpress program version 10 (Invitrogen). The edited sequences of the CSP gene from each isolate were translated to corresponding amino acid sequences using the ExPASy Translate tool (<http://web.expasy.org/translate/>). Deduced amino acid sequences were compared to CS protein sequences of *P. malariae* and *P. brasilianum* isolates available in the database.

3. Results {#s0015}
==========

3.1. Diagnosis of *P. malariae* infection {#s0050}
-----------------------------------------

The determination of malaria by conventional nested-PCR detected the presence of *P. malariae* DNA in 75 of 633 samples collected from different individuals in Yanomami villages, constituting an 11.8% carrier rate in this survey. 25 of 75 samples (33%) were co-infected with *P. vivax* (n = 7), *P. falciparum* (n = 12), or triple infections (n = 6) while the remaining 50 had mono-infections with quartan malaria parasites.

3.2. Differentiating *P. brasilianum* from *P. malariae* {#s0055}
--------------------------------------------------------

Out of the 75 samples PCR-positive for *P. malariae*, the 18S gene from 33 samples (27 mono-infections and 6 mixed infections) was successfully amplified and the resulting 763 bp product was analyzed by sequencing. Upon sequence analysis, 12 of the 33 samples had 18S gene sequences that were 100% identical with a *P. brasilianum* strain (GenBank [AF130735](ncbi-n:AF130735){#ir0250}) isolated from an infected monkey (*Alouatta seniculus*) in French Guiana ([@bb0040]). The twelve *P. brasilianum* infected individuals were from five different shabonos. The estimated ages of the patients were from 6 to 60 years.

In addition, isolates from four patients (n = 4) were 100% identical with the *P. malariae* Myanmar strain 1 (GenBank [AF487999](ncbi-n:AF487999){#ir0255}); six isolates (n = 6) were 100% identical with the *P. malariae* Myanmar strain 2 (GenBank [AF488000](ncbi-n:AF488000){#ir0260}); and one isolate (n = 1) was 100% identical with the *P. malariae* PNG strain (GenBank [AF145336](ncbi-n:AF145336){#ir0265}). The remaining ten isolates (n = 10) were 99% identical to either *P. malariae* Myanmar strain 2 or *P. malariae* PNG strain. Variation in the ten samples was represented by nucleotide polymorphisms (i.e., substitutions, insertions and/or deletions). Among these ten isolates, four new variants were identified (appendix).

Alignment of the twenty-three published 18S sequences and newly generated sequences of quartan malaria parasites showed 27 polymorphic sites in the 496-nucleotide sequences spanning V5 region. The overall nucleotide diversity (Pi) was 6.5 × 10^− 3^ (SD 0.001), with an average number of nucleotide differences (k) of 2.935.

[Table 1](#t0005){ref-type="table"} shows the extent of divergence in the genetic distances between *Plasmodium* species, as calculated from the 18S gene spanning variable domain 5. Although the quartan parasites were genetically distinct from the other *Plasmodium* species, there was no genetic differentiation between the *P. malariae* and *P. brasilianum* isolates (distance, d = 0.005). The average genetic distance between all quartan isolates from human and monkey is comparable to intra-species genetic distance in other *Plasmodium* spp. ([Table 1](#t0005){ref-type="table"}).

The phylogenetic analysis by the Neighbor joining method confirmed the similarity of all quartan malaria parasites (irrespective of the source of isolation, *P. brasilianum* or *P. malariae*) by clustering into a single monophyletic clade with a high bootstrap support of 100% ([Fig. 1](#f0005){ref-type="fig"}).

No identifying SNPs specific to either *P. malariae* or *P. brasilianum* was identified in the gene locus conventionally employed for differential diagnosis of malaria species. For example, all published *P. brasilianum* sequences isolated from monkeys and the twelve *P. brasilianum* sequences isolated from humans and sequenced in this study displayed G at position 565. However, the *P. brasilianum* isolate from Peru (MR4) sequenced in this study displayed an A, and three recently sequenced *P. malariae* isolates from humans in Costa Rica displayed a G at position 565 ([Table 2](#t0010){ref-type="table"}).

The new sequences identified in this study were submitted to the NCBI GenBank with accession numbers KJ619941--KJ619947KJ619941KJ619942KJ619943KJ619944KJ619945KJ619946KJ619947 and KM016331--KM016338KM016331KM016332KM016333KM016334KM016335KM016336KM016337KM016338.

3.3. Analysis of the *CSP* gene {#s0060}
-------------------------------

The central immunodominant repeat region of the CSP gene was amplified and sequenced from three isolates, each representing *P. brasilianum*, *P. malariae* Myanmar strain 1, and *P. malariae* Myanmar strain 2, identified by 18S gene sequencing. Translated amino acid sequences showed that all three isolates constituted the minor tandem tetrapeptide repeat unit NDAG (N, asparagine; D, aspartic acid; A, alanine; G, glycine) and the major unit NAAG (N, asparagine; A, alanine; G, glycine) varying only by the number of repeat units.

All published isolates from South America, including *P. brasilianum* and *P. malariae*, from this and other studies, started the repeat region with the tetrapeptide NDEG, which is similar to *P. malariae* isolates from Asia. In contrast, African isolates from Uganda, Cameroon, and Cote d\'Ivoire started the repeat region with NDAG ([Table 3](#t0015){ref-type="table"}).

4. Discussion {#s0020}
=============

All quartan malaria parasites analyzed in this study would be *P. malariae*, if they had been found fifteen years earlier. However, as [@bb0040] detected some 100% identical strains in monkeys in 1999, twelve of the 33 parasites had to be named *P. brasilianum*.

Based on phylogenetic analysis standards, *P. malariae* and *P. brasilianum* are one species ([Fig. 1](#f0005){ref-type="fig"}), and the punctual differences are not more than differences between strains of other *Plasmodium* species ([Tables 1 and 2](#t0005 t0010){ref-type="table"}). So far, the host made the difference, as the infected host has been the classification determinant for *P. malariae* and *P. brasilianum.* Our findings show that this distinction criterion no longer applies.

Malaria history surmises that 500 years ago, Old World Humans introduced *P. malariae* to the New World; some of the parasites crossed the species barrier, adapted to New World monkeys and became *P. brasilianum*, the simian quartan malaria parasite of Latin America ([@bb0015]). This hypothesis was challenged later; based on genetic diversity assumptions, it was reasoned that quartan parasites jumped from monkey to man and became human *P. malariae* ([@bb0095]). Though directions of the cross-species transfer are opposing, the two hypotheses share the common element of "host switching" which implies host specificity of *P. brasilianum* and *P. malariae* to monkey and man, respectively.

Our results allow an alternative view. For the first time, quartan malaria parasites, which are identical to those found in naturally infected primates of Latin America, were detected in naturally infected humans. Thus, our results provide evidence that quartan parasites are able to cross host species boundaries with impunity and that humans and non-human primates---in conditions of close contact---share quartan parasites without host specificity. Moreover, it can be speculated that *P. brasilianum* and *P. malariae* neither are distinct species, as the name suggests, nor are they distinct variants of one species, which became specialized on different hosts after switching, but are rather the same quartan malaria parasite species---an anthropozoonosis---circulating freely between monkeys and humans.

This confirmation of host sharing characteristics has long been pending [@bb0100; @bb0105] and might give a reason to re-appraise quartan malaria, a largely neglected disease thus far, with the qualities to become an emerging infection.

In 1890, *P. malariae* was the first malaria species to get a scientific name ([@bb0110]). To date, the causative agent of quartan malaria has been largely understudied, mainly because---due to low levels of parasitaemia---in most epidemiological surveys only a few infections were detected ([@bb0115]). Nonetheless, in studies with improved detection limits, *P. malariae* has been demonstrated in all malaria-endemic regions of the world [@bb0120] and therefore---strictly speaking---might be the malaria parasite with the widest geographical distribution.

Furthermore, quartan malaria parasites might represent the best adapted malaria parasites. The adaption of these protozoans to its hosts results in a mainly chronic clinical outcome with many carriers suffering no symptoms. It is well-known that quartan parasites can persist in dormancy for decades in the host without causing symptoms ([@bb0110]). For example, two chimpanzees, Takaboh and Oumu, acquired quartan *P. malariae*-like parasites in the African rain forest when they were babies, and the parasites remained undiscovered until detection 30 years after their first day of confinement in a Japanese zoo ([@bb0125]). This is perplexing because "hypnozoites"---as in *P. vivax* and *P. ovale*---have never been discovered or have not been well investigated.

What discriminates quartan malaria parasites from other *Plasmodium* spp. is their expansive reservoir of mammalian hosts. Besides the human host, there have been studies showing quartan malaria parasites in several dozens of monkey species. Merely in South America, quartan parasites were described in 35 monkey species (as *P. brasilianum*) ([@bb0040]). In Asia, monkeys are infected by the quartan *Plasmodium inui* ([@bb0015]), and in the African rain forest, great apes are infected by quartan parasites (as *Plasmodium rodhaini* or *P. malariae*, and *P. malariae*-like) ([@bb0005]). To our knowledge, this is by far the widest host reservoir compared with malaria of other periodicity.

Clinically, quartan malaria is considered as relatively harmless, but sufficient data are lacking to substantiate this assessment. Many investigators assume that *P. malariae* is the causal factor---perhaps with co-factors---for renal pathologies ([@bb0130]). Generally, it can be assumed that the clinical outcome of *P. malariae* infections is misinterpreted ([@bb0135]). Due to the chronic nature of the infection, capturing the true burden of the disease would require large longitudinal studies to assess the impact of the infection on occupational and social life of an individual.

Globally, the disease burden of quartan malaria is difficult to assess, because data on the incidence of *P. malariae* are faulty. The main reason is that *P. malariae* is principally underdiagnosed, because it thrives with a few hard-to-detect parasites, which are indistinguishable from *P. vivax* on the thick blood smear and which can also be misinterpreted as *P. falciparum*. Therefore, time-consuming reading of a thin smear or molecular methods would be necessary to identify this species. This explains why in the 1980s the Brazilian Health Ministry had "eradicated" *P. malariae* from Brazil by simply switching the official method of diagnosis from thin to thick blood smear ([@bb0140]).

In areas with marked variation in seasonal climate, *P. malariae* may account for 50% of the malaria episodes during the low-transmission season ([@bb0145]). As *P. malariae* is commonly found in sympatry with other *Plasmodium* species of humans, better understanding of species-interaction is necessary. Especially the interactions with *P. falciparum* in mixed infections is a controversially discussed topic ([@bb0115]). Recent seroepidemiological and biomolecular surveys indicated that the prevalence of *P. malariae* are underestimated [@bb0115; @bb0120] and high prevalences of *P. malariae* have been reported from Africa ([@bb0150]), Asia ([@bb0155]), and Latin America ([@bb0055]). These findings correspond well with results of our pilot study of the Upper Orinoco [@bb0065] which prompted us to undertake the current investigation.

Initially, we hypothesized that *P. brasilianum* and *P. malariae* might be discernible by 18S gene sequencing since we noticed that the SNP at position 565 was shared by all hitherto published *P. brasilianum* isolates. Consequently, we identified this SNP as a possible distinctive marker. However, when we sequenced the *P. brasilianum* Peruvian III strain (provided by MR4), our hypothesis was rebutted. It was rebutted a second time, when three *P. malariae* isolates from humans in Costa Rica were published during the revision process of this article displaying a G at position 565. It appeared that SNPs were distributed at random, and none was specific for *P. malariae* or *P. brasilianum* (see [Table 2](#t0010){ref-type="table"}).

To further ensure what was found in the 18S sequence, we analyzed the CS protein sequence, which also is used for species distinction, because the amino acid composition of the CSP gene is an adaptation for eliciting species specific antibody response. For example *P. vivax*, *P. falciparum* and *P. knowlesi* differ considerably in the CSP repeat region: *P. vivax*: DRAGGQPAG, *P. falciparum*: NANP, and *P. knowlesi*: GQPQAQGDGANA ([@bb0160]). The CS protein sequence was identical between *P. brasilianum* and *P. malariae*, consistent with results by other investigators (see [Table 3](#t0015){ref-type="table"}) ([@bb0105; @bb0165]).

So, unlike the zoonotic parasite *P. knowlesi*, which is genetically different from other *Plasmodium* spp. in several typical marker genes such as CSP and 18S genes (see [Table 1](#t0005){ref-type="table"}) ([@bb0105; @bb0170]), *P. brasilianum* is indistinguishable from *P. malariae* and infects the same hosts. And other than the two recently distinguished sympatric *P. ovale curtisi* and *P. ovale wallikeri* ([@bb0175]), the quartan parasites *P. malariae* and *P. brasilianum* do not segregate into distinct types in all genomic markers used so far (see [Fig. 1](#f0005){ref-type="fig"}) ([@bb0040; @bb0045; @bb0050]).

It has to be adverted, that logic does not allow demonstration of identity, or non-difference, even if a few whole genome sequences of the parasites were available. Hence, the best approach to show that the parasites are indeed one species would be to do cross-mating experiments. However, if no distinctive markers are known whereby the off-spring can be identified, these experiments are very difficult to design and it is questionable if they are ethically justified.

So far, the evidence of naturally acquired human infections with parasites termed as *P. brasilianum* was a missing piece in the puzzle of the identity of this quartan parasite ([@bb0060]). Based on the results presented here, we conclude that anthropozoonotic transmission of quartan malaria occurs in areas where the habitat of man and monkey overlap. Similar transmission scenarios wit simian participation have been reported in areas outside the Amazonian region, for example in the Atlantic Forest of Brazil ([@bb0180]).

We wonder if *P. brasilianum* will undergo a nomenclatorial revision, if further research confirms our findings. This would not be the first time that the name of a quartan malaria parasite is revised: In the 1940s, when *P. rodhaini*, the quartan parasite of apes in Africa, was identified to be *P. malariae*, the former name was soon "sinking into synonymy with *P. malariae*" ([@bb0015]) and is not anymore in use today. This was justified just recently: Alignment of the 18S sequences of *P. malariae* from humans in Bangladesh with the parasite sequences of one of the two simian immigrants in the Japanese zoo, Takaboh (GenBank Ac. [AB489195](ncbi-n:AB489195){#ir0280}), resulted in 100% identity (see also legend of [Fig. 1](#f0005){ref-type="fig"}) ([@bb0185]).

Malariologists know for some time that simian malaria will play an important role when human malaria eradication is envisaged ([@bb0190]). As quartan parasites are the only global human malaria parasites successfully infecting multiple mammalian hosts, they could evade control measures that do not account for the animal reservoir. These hidden and possibly emerging parasites could, therefore, represent an important area for future research efforts.
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![Neighbor Joining Tree based on 18S gene sequences of *Plasmodium* species. The tree shows that all quartan malaria parasites from humans and monkeys cluster into a monophyletic clade supported by a high bootstrap value of 99%. *P. brasilianum* and *P. malariae* sequences from this study are shown in color (red and blue). Hosts (non-human primate, human) are indicated by graphic symbols beside the taxa names. The sequence highlighted in red was found by Fandeur et al. in Alouatta monkeys, and in this study in humans. The two additional *P. malariae* isolates from human infections from Bangladesh (GenBank Ac. [KF906514](ncbi-n:KF906514){#ir0150} & GenBank Ac. [KF906514](ncbi-n:KF906514){#ir0155}); Fuehrer et al. showed that these two isolates were 100% identical with a *P. malariae-*like isolate from the Chimpanzee Takaboh (GenBank Ac. [AB489195](ncbi-n:AB489195){#ir0160}).](gr1){#f0005}

###### 

Estimates of the average genetic distance between and within *Plasmodium* spp.

The table shows average genetic distances based on variable domain 5 (V5) of the 18S gene sequences between (black) and within (red) *Plasmodium* spp. Standard errors (SE) for interspecies values (black) are shown above the diagonal (blue). The number of sequences (n) in each group of *Plasmodium* spp. is indicated in the second column. All V5 sequences generated in this study (including the MR4 sequence) and all comparable sequences from GenBank were included into the analysis. Sequences for *P. malariae* and *P. brasilianum* are listed in the supplementary appendix. Data show that genetic divergence between *P. brasilianum* and *P. malariae* is not more than within a species (gray boxes). Pmal, *P. malariae*; Pbra, *P. brasilianum*; Pfal, *P. falciparum*; Pviv, *P. vivax*; Pkno, *P. knowlesi*; Pcyn, *P. cynomolgi*; Poc, *P. ovale curtisi*; Pow, *P. ovale wallikeri*.

![](t1)

###### 

Nucleotide polymorphisms in 18S gene sequences of *P. brasilianum* and *P. malariae* isolates.

The table shows that no distinctive marker for *P. brasilianum* could be identified. The SNP positions given vertically above are numbered according to the nucleotide sequences of *P. brasilianum* (GenBank [AF130735](ncbi-n:AF130735){#ir0165}). Dots represent identical residues; dashes represent deletions. *P. brasilianum* and *P. malariae* sequences from this study are shown in red and blue, respectively. The numbers in brackets denote the number of identical isolates found in this study. Apart of the four *P. malariae* strains VEN1, VEN2, VEN3, and VEN4, all isolates identified in this study are identical to pre-existing *P. malariae*/*P. brasilianum* sequences.

![](t2)

###### 

Comparison and characterization of the circumsporozoite protein (CSP) central repeat region among quartan malaria species.

The table shows that the otherwise species-specific immunodominant repeat region of the CS protein is the same for all quartan malaria parasites. It consists of the major repeat unit NAAG and the minor repeat unit NDAG. Numbers of the repeat unit can change between isolates; this has been shown for all *Plasmodium* spp. Clones of PCR amplified CSP alleles from three isolates are displayed each representing *P. brasilianum*, *P. malariae* Myanmar strain 1, and *P. malariae* Myanmar strain 2, identified by 18S gene sequencing in this study. African isolates start with a NDAG unit, whereas isolates from Asia and South America (*P. malariae* and *P. brasilianum*) start with NDEG.

  Central immunodominant repeat units                                                                                                
  -------------------------------------- -------------------------------- ---------------------------- ------ ------ --- ------ ---- ----
  [KM016332](ncbi-n:KM016332){#ir0170}   *P. brasilianum*                 Venezuela (this study)       NDEG   NDAG   4   NAAG   50   54
  [KM016333](ncbi-n:KM016333){#ir0175}   *P. brasilianum*                 Venezuela (this study)       NDEG   NDAG   4   NAAG   50   54
  [KM016334](ncbi-n:KM016334){#ir0180}   *P. brasilianum*                 Venezuela (this study)       NDEG   NDAG   4   NAAG   50   54
  [KM016337](ncbi-n:KM016337){#ir0185}   *P. malariae* (Myanmar type 1)   Venezuela (this study)       NDEG   NDAG   4   NAAG   50   54
  [KM016338](ncbi-n:KM016338){#ir0190}   *P. malariae* (Myanmar type 1)   Venezuela (this study)       NDEG   NDAG   4   NAAG   49   53
  [KM016335](ncbi-n:KM016335){#ir0195}   *P. malariae* (Myanmar type 2)   Venezuela (this study)       NDEG   NDAG   5   NAAG   50   55
  [KM016336](ncbi-n:KM016336){#ir0200}   *P. malariae* (Myanmar type 2)   Venezuela (this study)       NDEG   NDAG   5   NAAG   51   56
  [AAA29553](ncbi-p:AAA29553){#ir0205}   *P. brasilianum*                 Unknown ([@bb0030])          NDEG   NDAG   5   NAAG   58   63
  [AGO33295](ncbi-p:AGO33295){#ir0210}   *P. brasilianum*                 Brazil ([@bb9000])           NDEG   NDAG   2   NAAG   21   23
  [AAA18618](ncbi-p:AAA18618){#ir0215}   *P. malariae* (China-1 CDC)      China ([@bb9100])            NDEG   NDAG   7   NAAG   46   53
  [AAA29557](ncbi-p:AAA29557){#ir0220}   *P. malariae* (Uganda-1 CDC)     Uganda ([@bb0030])           NDAG   NDAG   6   NAAG   45   51
  [CAA04809](ncbi-p:CAA04809){#ir0225}   *P. malariae*                    Cameroon ([@bb0165])         NDAG   NDAG   7   NAAG   44   51
  [CAA04812](ncbi-p:CAA04812){#ir0230}   *P. malariae*                    Cote d\'Ivoire ([@bb0165])   NDAG   NDAG   6   NAAG   46   52
